Company newsroom

bioAffinity Technologies, Inc.

NASDAQ:BIAF

1 releases

bioAffinity Technologies, Inc.17h ago

bioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization